To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Network meta-analysis of NSAIDs vs. diacerein vs. glucosamine in knee osteoarthritis treatment

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
August 2017

Network meta-analysis of NSAIDs vs. diacerein vs. glucosamine in knee osteoarthritis treatment

Vol: 6| Issue: 8| Number:21| ISSN#: 2564-2537
Study Type:Meta-analysis/Systematic Review
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Efficacy and safety of glucosamine, diacerein, and NSAIDs in osteoarthritis knee: a systematic review and network meta-analysis

Eur J Med Res. 2015 Mar 13;20:24

Contributing Authors:
P Woratanarat J Kongtharvonskul M McEvoy J Attia A Thakkinstian T Anothaisintawee

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

31 randomized controlled trials were included in this network meta-analysis comparing the efficacies of diacerein, glucosamine, non-steroid anti-inflammatory drug therapy, and placebo in patients with knee osteoarthritis. Relative to placebo, indirect comparisons demonstrated each of diacerein, glucosamine, and NSAID therapy had significantly greater effects on pain reduction, though the relative ...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue